These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors]. Tunçcan OG; Ulutan F; Karakuş R Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078 [TBL] [Abstract][Full Text] [Related]
5. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods]. Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea. Heimesaat MM; Granzow K; Leidinger H; Liesenfeld O Infection; 2005 Oct; 33(5-6):340-4. PubMed ID: 16258864 [TBL] [Abstract][Full Text] [Related]
8. Incidence of Clostridium difficile infection in children with inflammatory bowel disease compared to oncology and immunocompetent patients. Hojsak I; Ferenc T; Bojanić K; Mišak Z; Močić Pavić A; Lukić-Grlić A; Kolaček S Digestion; 2012; 86(1):6-11. PubMed ID: 22688504 [TBL] [Abstract][Full Text] [Related]
9. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile. Bishara J; Peled N; Pitlik S; Samra Z J Hosp Infect; 2008 Apr; 68(4):308-14. PubMed ID: 18353491 [TBL] [Abstract][Full Text] [Related]
10. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents. Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M; Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540 [TBL] [Abstract][Full Text] [Related]
11. Limited clinical utility of Clostridium difficile toxin testing in infants in a pediatric hospital. Tang P; Roscoe M; Richardson SE Diagn Microbiol Infect Dis; 2005 Jun; 52(2):91-4. PubMed ID: 15964495 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Clostridium difficile toxin in diarhoeal stool samples of patients from a tertiary hospital in North Eastern Penisular Malaysia. Hassan SA; Othman N; Idris FM; Abdul Rahman Z; Maning N; Abdul Rahman R; Tiong CG Med J Malaysia; 2012 Aug; 67(4):402-5. PubMed ID: 23082450 [TBL] [Abstract][Full Text] [Related]
13. Estimation of faecal carriage of Clostridium difficile in patients with ulcerative colitis using real time polymerase chain reaction. Balamurugan R; Balaji V; Ramakrishna BS Indian J Med Res; 2008 May; 127(5):472-7. PubMed ID: 18653911 [TBL] [Abstract][Full Text] [Related]
14. [Six years evaluation of Clostridium difficile associated diarrhea]. Ercis S; Ergin A; Hasçelik G Mikrobiyol Bul; 2004; 38(1-2):45-50. PubMed ID: 15293901 [TBL] [Abstract][Full Text] [Related]
15. The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea. van Langenberg DR; Gearry RB; Wong HL; Ward M; Gibson PR Intern Med J; 2010 Dec; 40(12):819-27. PubMed ID: 19849752 [TBL] [Abstract][Full Text] [Related]
16. Impact of Clostridium difficile on inflammatory bowel disease. Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234 [TBL] [Abstract][Full Text] [Related]